Showing results (361-370 of 470) with videos related to

Sort By:
Pageof 47
Breast Cancer Research and Treatment|May 20, 2023
Clinical outcomes and prognostic factors in triple-negative invasive lobular carcinoma of the breastUtsav Joshi, Pravash Budhathoki, Suman Gaire, et al.
Therapeutic Advances in Medical Oncology|February 9, 2023
Efficacy and safety results by menopausal status in monarchE: adjuvant abemaciclib combined with endocrine therapy in patients with HR+, HER2-, node-positive, high-risk early breast cancerShani Paluch-Shimon, Patrick Neven, Jens Huober, et al.
JCI Insight|July 24, 2020
Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole actionJunmei Cairns, James N Ingle, Tanda M Dudenkov, et al.
Nature Communications|January 27, 2022
Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilitiesNicola Cosgrove, Damir Varešlija, Stephen Keelan, et al.
Pharmacogenetics and Genomics|July 11, 2020
Single-nucleotide polymorphism biomarkers of adjuvant anastrozole-induced estrogen suppression in early breast cancerJames N Ingle, Krishna R Kalari, Poulami Barman, et al.
Molecular Endocrinology (Baltimore, Md.)|March 23, 2013
TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expressionMohan Liu, James N Ingle, Brooke L Fridley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2021
Characteristics and Spatially Defined Immune (micro)landscapes of Early-stage PD-L1-positive Triple-negative Breast CancerJodi M Carter, Mei-Yin C Polley, Roberto A Leon-Ferre, et al.
Cancers|August 28, 2020
Perspectives on Triple-Negative Breast Cancer: Current Treatment Strategies, Unmet Needs, and Potential Targets for Future TherapiesGagan K Gupta, Amber L Collier, Dasom Lee, et al.
Cancer Discovery|June 15, 2013
Selective estrogen receptor modulators and pharmacogenomic variation in ZNF423 regulation of BRCA1 expression: individualized breast cancer preventionJames N Ingle, Mohan Liu, D Lawrence Wickerham, et al.
Breast Cancer Research and Treatment|September 16, 2017
Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancerRoberto A Leon-Ferre, Mei-Yin Polley, Heshan Liu, et al.
Pageof 47